Text Size

A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study

Leonardi A., Doan S., Amrane M., Ismail D., Montero J., Németh J., Aragona P., Bremond-Gignac D., VEKTIS Study Group

  • 2019
  • Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Department of Ophthalmology, Bichat Hospital and Foundation A. de Rothschild, Paris, France; Global Research and Development, Santen SAS, Evry, France; Clinica Cartuja Vision, Ophthalmological Center, Universidad de Sevilla, Sevilla, Spain; Department of Ophthalmology, Semmelweis University, Budapest, Hungary; Department of Biomedical Science, University of Messina, Messina, Italy; University Hospital Necker Enfants Malades, APHP, and Rare Eye Disease Center OPHTARA, CNRS Unit FR3636, Paris Descartes University, Paris, France

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022